Press Releases
April 13, 2021
TFF Pharmaceuticals Awarded Contract under DARPA’s Next-Generation Personalized Protective Biosystems Program for U.S. Warfighters
TFF Pharmaceuticals Prices Offering of Common StockMarch 26, 2021
TFF Pharmaceuticals Prices Offering of Common Stock
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Business ResultsMarch 10, 2021
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Business Results
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility CollaborationMarch 9, 2021
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
Feasibility Arrangement for Shelf-stable Powder Form of Messenger RNA COVID-19 Vaccine Candidate Announced by GreenLight Biosciences and TFF PharmaceuticalsMarch 9, 2021
Feasibility Arrangement for Shelf-stable Powder Form of Messenger RNA COVID-19 Vaccine Candidate Announced by GreenLight Biosciences and TFF Pharmaceuticals
TFF Pharmaceuticals to Present at Virtual Investor Conferences in March 2021March 5, 2021
TFF Pharmaceuticals to Present at Virtual Investor Conferences in March 2021
TFF Pharmaceuticals Provides Update on Clinical Development ProgramsMarch 4, 2021
TFF Pharmaceuticals Provides Update on Clinical Development Programs
TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2020 Financial Results and Business Results Conference Call on March 10, 2021February 24, 2021
TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2020 Financial Results and Business Results Conference Call on March 10, 2021
TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)February 19, 2021
TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
TFF Pharmaceuticals to Present at the BIO CEO & Investor Digital ConferenceFebruary 12, 2021
TFF Pharmaceuticals to Present at the BIO CEO & Investor Digital Conference